USPH Q4 GAAP EPS loss $0.01; adjusted EBITDA up 2.8%; raises dividend 4.9% to $0.43; guides 2023 EBITDA $75-80M

U S PHYSICAL THERAPY INC /NV

2022-FY EPS reported $2.25 revenue$553,144,000

Q4 net income $2.6M vs $10.2M YoY; GAAP diluted EPS loss $0.01 (incl. $9.1M goodwill impairment).
Adjusted EBITDA $17.9M (+2.8% YoY); Operating Results $0.58/diluted share vs $0.72 (excl relief funds).
Full year 2022 revenue $553.1M (+11.7%); net patient revenue from PT $464.6M (+6.0%).
IIP services revenue $77.1M (+75.5% YoY); two Q4 acquisitions added 27 clinics.
Board raised quarterly dividend to $0.43/share (+4.9%); 2023 Adjusted EBITDA guidance $75-80M.

item 2.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

U S PHYSICAL THERAPY INC /NV reported financial results for three months and year ended December 31, 2022.

Period: three months and year ended December 31, 2022
Result: reported results

Exact text from the filing

On February 22, 2023, U.S. Physical Therapy, Inc. ("USPH" or the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention (“IIP”) services, reported results for the three months and year ended December 31, 2022 (“2022 Fourth Quarter” and “2022 Year”, respectively).

View on SEC.gov

31 earnings releases filed in the last 30 days. Browse all earnings releases →

U S PHYSICAL THERAPY INC /NV filing history →

Source: SEC EDGAR

accession 0000885978-23-000004

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.